Fidelity
Home > Boards > US OTC > Miscellaneous >

Seratosa Inc. (STOA)

STOA RSS Feed
Add STOA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator sunspotter, Quiver-Full
Search This Board:
Last Post: 4/10/2014 8:52:11 AM - Followers: 230 - Board type: Free - Posts Today: 0



Business Description
Sitoa Global Announces Exclusive Letter of Intent With UC San Francisco, New Business Strategy and Corporate Restructuring

HONG KONG, CHINA--(Marketwired - Nov 25, 2013) - Sitoa Global Inc. ("Sitoa Global", or "the Company") (OTCQB: STOA) announced today that it entered into an exclusive letter of intent ("LOI") with the University of California, San Francisco ("UCSF") to negotiate an option agreement in regards to the exclusive global licensing of a medical stereotactic device (the "Device") which the Company believes has the potential to revolutionize the delivery of stem cells into the human brain and enhance the efficacy of a wide range of stem cell therapeutics. Beyond stem cells, the platform technology of the device can also enable the delivery of cellular therapeutics, gene therapies, and traditional drug infusions into the human brain.

The Stem Cell industry is one of the fastest growing and most compelling areas in medicine with numerous companies and research institutions spending hundreds of millions of dollars per year on the development of new therapies and devices. The Company believes that the Device could become the preferred tool for the deployment of stem cells into the human brain for any company or clinician conducting clinical trials and providing experimental treatment in this field. Therefore, the use of the Device could become analogous to the use of 'picks and shovels' during the historical gold rush and allow the Company to pursue such a picks-and-shovels business model and to participate in the growth of the Stem Cell industry as a provider of tools and resources.

The LOI with UCSF and the impending change in business strategy is expected to enable the Company to enter an exciting and high growth industry that is experiencing rapid growth and significant private and public funding opportunities. As a result, the Company is expected to undergo a corporate restructuring in order to enhance shareholder value, to dispose of all its e-commerce and software businesses, and to add industry-relevant expertise to the management team and board.

The Opportunity in the Stem Cell Market

There are numerous companies worldwide that are currently doing research with Regenerative Medicine and Stem Cell technologies. According to the VisionGain Stem Cell Industry Report 2012-2013, the estimated market size for regenerative medicine is $10.7 billion in 2017 ramping up to approx. $22 billion by 2020.

About The Device

Over 9 million patients in the United States suffer from a wide range of neurological disorders including Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis. Promising stem cell therapies for these disorders are being developed, but most require direct delivery of such cell-based therapeutics to specific brain regions.

Currently available neurosurgical devices can deliver a straight, rigid needle to single brain locations. However, this basic strategy limits the size and "shape" of the brain treatment area. In order to deliver to larger and more complex brain targets, the surgeon needs to penetrate the brain multiple times with such straight needles, which may reduce the efficacy of stem cell therapeutics and increase the risk of bleeding and stroke.

The Device enables the radial deployment of a flexible delivery catheter to large and anatomically complex brain targets through a single initial brain penetration. Thus, the Device allows clinicians to "tailor" therapeutic stem cell delivery to individual patient anatomy and specific disease targets, which may enhance the efficacy of a wide range of stem cell therapies. This modern and "easy to use" platform technology allows "real-time" monitoring of therapeutic delivery under interventional MRI guidance (iMRI), which can improve the accuracy of cell delivery, reduce the risk of complications, and increase patient safety.

To date, the Device has been developed at UCSF with $1.8 million in funding from the California Institute for Regenerative Medicine (CIRM). This initial funding of basic research and development has alleviated much of the early risk associated with developing a new breakthrough technology. It is anticipated that this funding could allow the Device to file for US FDA 510(k) approval by the middle of 2014.

The California Institute for Regenerative Medicine was created by California's Proposition 71 in 2004, which authorized it to issue $3 billion in grants over ten years for embryonic stem cell and other biomedical research. It is believed to be the world's largest single backer of research in stem cells.

UCSF has a patent application filed and pending on the intellectual property of the Device.

About UCSF

The University of California, San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF is the nation's top public recipient of funding from the National Institutes of Health (NIH), in research and education in such areas as cancer, cardiovascular disease, diabetes, infectious diseases, neurology and stem cells. UCSF and each of its schools have ranked among the top four in NIH funding for more than a decade, reflecting the caliber of research and education being performed at the University.

         SEC Filings(STOA)
            
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
STOA
Current Price
Volume:
Bid Ask Day's Range
Wiki
STOA News: Sitoa Global Announces Exclusive Letter of Intent With UC San Francisco, New Business Strategy and Corporate Restructuring 11/25/2013 07:30:00 AM
PostSubject
#23919  Sticky Note STOA S era TO s A[/col Quiver-Full 12/11/13 07:09:58 AM
#16104  Sticky Note STOA DD Compilation by: Plague Plague 07/16/13 04:31:38 PM
#12149  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 06/22/13 03:54:48 PM
#24279   Sounds like every other stinky pinky scam. Wang WarMachine 04/10/14 08:52:11 AM
#24278   Hearing that Wang is on the way out Ixtlan 04/10/14 07:14:30 AM
#24277   Another one... skaman069 04/08/14 11:50:38 AM
#24276   Someone who Needs money and sells with serious goodyboy 04/04/14 12:47:48 PM
#24275   Random... volume today??? skaman069 04/04/14 10:19:57 AM
#24274   wow...anybody reported these guys to SEC yet?? sandtrap246 03/29/14 02:18:16 AM
#24273   Lol, go! 12yearplan 03/18/14 03:22:25 PM
#24272   Possibly disposable umbrellas. Or maybe the device Stockhunter22 03/18/14 03:19:01 PM
#24271   STOA get into poultry farming? 12yearplan 03/18/14 02:29:50 PM
#24270   Yes but then I would have even less chetntam 03/13/14 08:14:00 AM
#24269   maybe after an other RS ... Anonymous777 03/12/14 11:53:30 PM
#24268   Again 500 shares bought @ ask.... 0,75 Perhaps goodyboy 03/12/14 11:27:34 AM
#24267   Who would ever do that??? skaman069 03/11/14 05:47:39 PM
#24266   It's up because someone unaware bought the ask Stockhunter22 03/11/14 05:44:31 PM
#24265   Lol , my 24M shares ended up 2.4k pikhenry 03/11/14 04:45:23 PM
#24264   I agree... I need at least $35/share increase chetntam 03/11/14 04:04:24 PM
#24263   Yes it is but why is it up? skaman069 03/11/14 03:53:33 PM
#24262   No way. This company is a giant Stockhunter22 03/11/14 01:21:12 PM
#24261   STOA is looking great at this level kranthikumar 03/11/14 10:56:21 AM
#24260   Is news coming that they are jumping into chetntam 03/11/14 10:29:36 AM
#24259   This stock needs to get into MMJ. About BigJuan 02/24/14 09:37:09 PM
#24257   What this stock needs is a forward split. moras 02/14/14 03:29:55 PM
#24254   Wang Wonged Investors = Fish POOP = Bass Tadaaa 02/11/14 07:28:23 PM
#24253   Well it's not dilution... Retail selling New OS: 451,022 Quiver-Full 02/11/14 05:05:28 PM
#24252   That's correct. No one is buying this Stockhunter22 02/10/14 01:20:33 PM
#24251   I have entered an order to sell on dallas71 02/10/14 11:50:06 AM
#24250   Get your money back ASAP Russmax 02/07/14 10:38:24 AM
#24249   we all lost the money in this scam ... Anonymous777 02/05/14 10:48:17 PM
#24248   Can't believe anyone would even consider buying at WarMachine 02/04/14 10:01:51 PM
#24247   hear hayn 02/04/14 08:04:56 PM
#24246   He's a dead man walking. I'll probably hayn 02/04/14 08:00:53 PM
#24245   There are certainly shares available apparently. More dallas71 02/04/14 03:12:10 PM
#24244   Couldn't agree more. dallas71 02/04/14 03:07:09 PM
#24243   That crook Wang and his company will never Stockhunter22 02/04/14 02:55:54 PM
#24242   :) are you going to sell? Don't know goodyboy 02/04/14 02:48:07 AM
#24241   Can someone tell me why TDA won't let dallas71 02/03/14 03:05:53 PM
#24240   That I know thought you were referring to BigJuan 02/01/14 09:12:39 AM
#24239   Check with TA regarding the OS my friend. Stockhunter22 02/01/14 07:56:15 AM
#24238   5k volume = dumping shares?????? The Wang is BigJuan 01/31/14 07:54:07 PM
#24237   Loser wang still dumping shares lol Stockhunter22 01/31/14 05:36:18 PM
#24236   Anybody know why TDA won't even let me dallas71 01/31/14 03:05:00 PM
#24235   Nice painting down ... Wonder who is the goodyboy 01/23/14 02:07:54 AM
#24234   LOL How strategic was that? http://ih.advfn.com/p.php?pid=squote&symbol=STOA WarMachine 01/22/14 07:49:27 PM
#24233   WOW! Those day one crashes are a MFer. WarMachine 01/22/14 07:44:33 PM
#24232   WANG = Loser, Tar n Feather !! Tadaaa 01/22/14 05:10:06 PM
#24231   Someone more info about http://gogibute54.blog.fc2.com/blog-entry-119.html ? goodyboy 01/21/14 12:31:16 PM
#24230   Wangster releases financials at 10pm on a Friday Stockhunter22 01/17/14 10:06:15 PM
#24229   Another stellar day for STOA is almost wrapped up. dallas71 01/17/14 03:49:08 PM
#24228   I think the answer is yes... If they Quiver-Full 01/17/14 10:39:19 AM
#24226   Will they be releasing a Q4 / tpell 01/17/14 10:03:23 AM
PostSubject